Identification of Cardiometabolic Protein Biomarkers for Acute Myocardial Infarction Using Olink Proteomics
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Background: Acute myocardial infarction (AMI) is a critical cardiovascular event characterized by sudden coronary blood flow interruption, leading to myocardial ischemia and necrosis. Despite advances in acute therapeutic measures, understanding the metabolic damage related to AMI, particularly through specific protein expressions, remains limited. This study utilized Olink cardiovascular metabolomics technology to explore cardiovascular metabolism-related protein biomarkers associated with AMI, aiming to address the clinical need for early diagnosis and targeted therapy. Methods: This study utilized Olink cardiovascular metabolomics technology to analyze 92 cardiovascular metabolism-related proteins in coronary blood samples from 20 AMI patients and 10 healthy controls. Differentially expressed proteins were identified using statistical t-tests, followed by functional enrichment analysis (GO and KEGG) and protein-protein interaction network construction. Five core proteins were validated in plasma samples from an additional 125 AMI patients and 120 healthy controls via enzyme-linked immunosorbent assay. To evaluate diagnostic performance, receiver operating characteristic curves were generated using GEO-related datasets, and Mendelian randomization analysis was employed to investigate the causal relationship between core proteins and AMI risk. Results: The study identified 32 proteins with significantly altered expression levels between AMI patients and healthy controls. Among these, five core proteins-PCOLCE, FCN2, REG1A, DEFA1, and CRTAC1-were significantly associated with key biological processes such as metabolism, collagen formation, and the PI3K/AKT signaling pathway. These proteins showed strong correlations with clinical indicators, including BMI, LVEF, NT-proBNP, CK-MB, and cTnT. FCN2 and DEFA1 were further validated as having a causal relationship with AMI risk, indicating their potential as diagnostic biomarkers. Conclusion: The identified core proteins PCOLCE, FCN2, REG1A, DEFA1, and CRTAC1 are potential biomarkers for the early diagnosis and risk assessment of AMI. These findings suggest that these proteins could serve as targets for future therapeutic interventions aimed at mitigating cardiovascular metabolic damage in AMI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Plasma REG1A has been shown to be elevated in acute myocardial infarction, indicating a role in cardiovascular stress response 33 .”
From Connecting proteomics and genomics to identify causal biomarkers specific for aortic valve stenosis (2025) · cites this paper as [33]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rossello, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G.-A., Dweck, M. R., Galbraith, M., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad191 · Cited by 5,333
FinnGen provides genetic insights from a well-phenotyped isolated population
Kurki, M. I., Karjalainen, J., Palta, P., Sipilä, T. P., Kristiansson, K., Donner, K. M., Reeve, M. P., Laivuori, H., Aavikko, M., Kaunisto, M. A., et al. (2023) · Nature · doi:10.1038/s41586-022-05473-8 · Cited by 4,233
Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart
Fu, X., Khalil, H., Kanisicak, O., Boyer, J. G., Vagnozzi, R. J., Maliken, B. D., Sargent, M. A., Prasad, V., Valiente-Alandi, I., Blaxall, B. C., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98215 · Cited by 636 · cited 1×
“43 Vascular smooth muscle cells (VSMCs) switch from a contractile phenotype to a synthetic phenotype, promoting vascular remodeling and the development of atherosclerosis.”
How vascular smooth muscle cell phenotype switching contributes to vascular disease
Cao, G., Xuan, X., Hu, J., Zhang, R., Jin, H., & Dong, H. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00993-2 · Cited by 431
The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases
Toldo, S., & Abbate, A. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00946-3 · Cited by 411
Decoding the transcriptome of calcified atherosclerotic plaque at single-cell resolution
Alsaigh, T., Evans, D., Frankel, D., & Torkamani, A. (2022) · Communications Biology · doi:10.1038/s42003-022-04056-7 · Cited by 216
Smith, J. G., & Gerszten, R. E. (2017) · Circulation · doi:10.1161/circulationaha.116.025446 · Cited by 206
Optimized human intestinal organoid model reveals interleukin-22-dependency of paneth cell formation
He, G.-W., Lin, L., DeMartino, J., Zheng, X., Staliarova, N., Dayton, T., Begthel, H., van de Wetering, W. J., Bodewes, E., van Zon, J., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.08.002 · Cited by 178
Günata, M., & Parlakpınar, H. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3587 · Cited by 135
Cited by
Zhang, T., Zhang, G., Liu, T., Gu, T., Yu, F., Xu, P., Mi, W., Zhao, X., Guo, Q., Zheng, H., et al. (2026) · Med Research · doi:10.1002/mdr2.70052 · Cited by 5
Self-citationPei, X., Cui, F., Chen, Y., Yang, Z., Xie, Z., & Wen, Y. (2025) · Clinical Interventions in Aging · doi:10.2147/cia.s550861 · Cited by 1
Dlouhá, D., Pompach, P., Horackova, J., Hubacek, J. A., & Blaha, V. (2026) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.70043 · Cited by 1
Visuttijai, K., Hedberg‐Oldfors, C., Braun, O. B., Englund, E., Glamuzina, E. E., TURNER, C., Vukušić, K., Sandstedt, J., Dellgren, G., Karason, K., et al. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag212 · Cited by 1
Connecting proteomics and genomics to identify causal biomarkers specific for aortic valve stenosis
Zamani, P., Houessou, U., Manikpurage, H. D., Dahmene, M., Li, Z., Gaudreault, N., Clavel, M.-A., Pibarot, P., Mathieu, P., Arsenault, B. J., et al. (2025) · medRxiv · doi:10.1101/2025.11.27.25339923
“Plasma REG1A has been shown to be elevated in acute myocardial infarction, indicating a role in cardiovascular stress response 33 .”
Metadata
- Authors
- Tan, X., Wang, X., Xu, S., Zeng, Y., Zhang, G., Xu, A., Jiang, Y., Jiang, H., Song, Y., Fan, J., Fu, Y., Bo, X., Fan, H., & Zhou, Y.
- Affiliations
- Soochow University (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Third People's Hospital of Hefei (CN)
- Corresponding author
- Fan, Huimin
- Zhou, Yafeng
- Venue
- Journal of Inflammation Research
- Publisher
- Informa UK Limited
- Published
- 2025-02
- Volume
- Volume 18
- Pages
- 2629-2646
- ISSN
- 1178-7031 (ISSN-L)
- PMC
- PMC11863793
- OpenAlex
- W4407810609
- Cited by
- 8
- References
- 36
- Citations by year
- 2026: 6 · 2025: 2
- FWCI
- 5.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Inflammation Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (acceptedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- acute myocardial infarction, DEFA1, REG1A, CRTAC1, PI3K/Akt signaling, early diagnosis, risk assessment, Mendelian randomization, NT-proBNP, cTnT
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.